Skip to main content
OpenTrials

Clinical trial condition

HER2-negative Breast Cancer

Explore clinical trials studying HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

109 public trials 55 recruiting studies
Refine in advanced search Browse all conditions

HER2-negative Breast Cancer trial results

Recruiting

A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

NCT06999187

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +55 more
Locations
  • Dren Investigational Site Denver, Colorado, United States
  • Dren Investigational Site Orlando, Florida, United States
  • Dren Investigational Site Sarasota, Florida, United States
  • Dren Investigational Site Huntersville, North Carolina, United States
View Trial Details
Recruiting

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

NCT05216432

Conditions
Advanced Breast Cancer, Breast Cancer, Breast Diseases, +10 more
Locations
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • University of California-San Diego San Diego, California, United States
  • HealthONE Denver, Colorado, United States
  • Yale University New Haven, Connecticut, United States
View all 37 locations
View Trial Details
Recruiting

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

NCT06568692

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • FOMAT Medical Research Oxnard, California, United States
  • AP Medical Research Miami, Florida, United States
View all 13 locations
View Trial Details

Related conditions